ResMed

ResMed ResMed is a leading respiratory medical device manufacturer, specializing in products for the diagnosis and treatment of sleep disordered breathing (SDB).

When ResMed was formed in 1989, its primary purpose was to commercialize a device for treating obstructive sleep apnea (OSA), a major subset of SDB. Developed in 1981 by Professor Colin Sullivan and colleagues at the University of Sydney, nasal continuous positive airway pressure (CPAP) provided the first successful noninvasive treatment of OSA. Since 1989, ResMed has maintained its focus on SDB, which is gaining greater public and physician awareness.

Innovation has played a major role in ResMed's success. Since the company's founding in 1989, a large number of product advancements and improvements designed to increase patient comfort and encourage compliance with therapy have been developed. Feedback from patients and specialists around the world is used to produce products that meet the different market needs. At the end of June 1999, the Company had a total of 186 patents issued and pending for a range of technologies.

ResMed Products

ResMed customer service can be reached at: (800) 424-0737